Delivery Order SPE2DB20D1004-SPE2DB23FF6G3
Award Date 4/10/23
Potential Completion Date 4/11/23
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $15,255.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of December 22, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $7,774.21, is for a delivery order to provide ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This federal contract award, valued at $45,235.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of May 22, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award, valued at $13,185.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product, to support military treatment facilities,...
- This federal contract award, valued at $5,760.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of February 8, 2024 and a Firm Fixed Price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support...
- This federal contract award, valued at $107,280.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 2.5 mg tablets, a pharmaceutical product used in the treatment of various medical conditions. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $9,546.07, is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product. The contract was awarded on December 8, 2023, with a completion date of December 11, 2023. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, with a ceiling value of $1,151.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Eliquis 2.5 mg tablets, a pharmaceutical product used for the treatment of cardiovascular conditions. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
- This federal contract award, valued at $12,275.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of Eliquis 5 mg tablets, a medication used for the treatment of various cardiovascular conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,324.32 firm fixed-price delivery order is for the supply of ELIQUIS 2.5 MG TABLET 60S, which are pharmaceutical products used for various medical purposes. The award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical....
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FF6G3Delivery Order
This federal contract award, valued at $2,283.71, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 12:11 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/10/23 |